Literature DB >> 33432032

Lies, Gosh Darn Lies, and not enough good statistics: why epidemic model parameter estimation fails.

Daniel E Platt1, Laxmi Parida2, Pierre Zalloua3,4.   

Abstract

We sought to investigate whether epidemiological parameters that define epidemic models could be determined from the epidemic trajectory of infections, recovery, and hospitalizations prior to peak, and also to evaluate the comparability of data between jurisdictions reporting their statistics. We found that, analytically, the pre-peak growth of an epidemic underdetermines the model variates, and that the rate limiting variables are dominated by the exponentially expanding eigenmode of their equations. The variates quickly converge to the ratio of eigenvector components of the positive growth mode, which determines the doubling time. Without a sound epidemiological study framework, measurements of infection rates and other parameters are highly corrupted by uneven testing rates, uneven counting, and under reporting of relevant values. We argue that structured experiments must be performed to estimate these parameters in order to perform genetic association studies, or to construct viable models accurately predicting critical quantities such as hospitalization loads.

Entities:  

Year:  2021        PMID: 33432032      PMCID: PMC7801491          DOI: 10.1038/s41598-020-79745-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  34 in total

1.  Dynamics of coronavirus replication-transcription complexes.

Authors:  Marne C Hagemeijer; Monique H Verheije; Mustafa Ulasli; Indra A Shaltiël; Lisa A de Vries; Fulvio Reggiori; Peter J M Rottier; Cornelis A M de Haan
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

2.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

Authors:  Shaobo Shi; Mu Qin; Bo Shen; Yuli Cai; Tao Liu; Fan Yang; Wei Gong; Xu Liu; Jinjun Liang; Qinyan Zhao; He Huang; Bo Yang; Congxin Huang
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

Review 3.  Coronaviruses: an overview of their replication and pathogenesis.

Authors:  Anthony R Fehr; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2015

4.  Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.

Authors:  Jay J H Park; Eric H Decloedt; Craig R Rayner; Mark Cotton; Edward J Mills
Journal:  Lancet Glob Health       Date:  2020-08-20       Impact factor: 26.763

5.  Observed and estimated prevalence of Covid-19 in Italy: How to estimate the total cases from medical swabs data.

Authors:  F Bassi; G Arbia; P D Falorsi
Journal:  Sci Total Environ       Date:  2020-10-08       Impact factor: 7.963

6.  Effects of Latency on Estimates of the COVID-19 Replication Number.

Authors:  Lorenzo Sadun
Journal:  Bull Math Biol       Date:  2020-08-20       Impact factor: 1.758

7.  Will children reveal their secret? The coronavirus dilemma.

Authors:  Luca Cristiani; Enrica Mancino; Luigi Matera; Raffaella Nenna; Alessandra Pierangeli; Carolina Scagnolari; Fabio Midulla
Journal:  Eur Respir J       Date:  2020-04-23       Impact factor: 16.671

8.  Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020.

Authors:  Tapiwa Ganyani; Cécile Kremer; Dongxuan Chen; Andrea Torneri; Christel Faes; Jacco Wallinga; Niel Hens
Journal:  Euro Surveill       Date:  2020-04

9.  Coronavirus Disease Model to Inform Transmission-Reducing Measures and Health System Preparedness, Australia.

Authors:  Robert Moss; James Wood; Damien Brown; Freya M Shearer; Andrew J Black; Kathryn Glass; Allen C Cheng; James M McCaw; Jodie McVernon
Journal:  Emerg Infect Dis       Date:  2020-09-28       Impact factor: 6.883

10.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.